2013 - Review: bDMARDs plus conventional synthetic DMARDs have greater efficacy than either alone in RA.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Abstract:
      The article discusses the research study conducted to examine the efficacy of biological disease-modifying antirheumatic drugs that were recommended for the management of rheumatoid arthritis. Topics discussed include role of biologic disease-modifying antirheumatic drug (bDMARD) in treating rheumatoid arthiritis, improvement in disease activity, and drug efficacy, and source of funding of the study European League Against Rheumatism (EULAR).